Selecting high-risk individuals for lung cancer screening: A prospective evaluation of existing risk models and eligibility criteria in the German EPIC cohort

Cancer Prevention Research

Volumn 8, Issue 9, 2015, Pages 777-785

  Li, Kuanrong ^a   Hüsing, Anika ^a   Sookthai, Disorn ^a   Bergmann, Manuela ^b   Boeing, Heiner ^b   Becker, Nikolaus ^a   Kaaks, Rudolf ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER SCREENING; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EVALUATION STUDY; FEMALE; GERMANY; HIGH RISK POPULATION; HUMAN; LUNG CANCER; MALE; MODEL; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SMOKING; VALIDATION STUDY; ALGORITHM; CLINICAL TRIAL (TOPIC); EARLY CANCER DIAGNOSIS; LUNG NEOPLASMS; MASS SCREENING; MIDDLE AGED; PROCEDURES; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; THEORETICAL MODEL; TREATMENT OUTCOME;

ADULT; AGED; ALGORITHMS; CLINICAL TRIALS AS TOPIC; EARLY DETECTION OF CANCER; FEMALE; GERMANY; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; MODELS, THEORETICAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SMOKING; TREATMENT OUTCOME;

EID: 84941780278     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-14-0424     Document Type: Article

References (41)

1. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
2. Van Iersel CA, De Koning HJ, Draisma G, Mali WP, Scholten ET, Nackaerts K, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007;120:868-74
3. Pedersen JH, Ashraf H, Dirksen A, Bach K, Hansen H, Toennesen P, et al. The Danish randomized lung cancer CT screening trial-overall design and results of the prevalence round. J Thorac Oncol 2009;4:608-14.
4. Lopes PA, Picozzi G, Mascalchi M, Maria CF, Carrozzi L, Comin C, et al. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 2009;64:34-40.
5. Infante M, Cavuto S, Lutman FR, Brambilla G, Chiesa G, Ceresoli G, et al. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med 2009;180:445-53.
6. Becker N, Motsch E, Gross ML, Eigentopf A, Heussel CP, Dienemann H, et al. Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round. J Cancer Res Clin Oncol 2012;138:1475-86.
7. Baldwin DR, Duffy SW, Wald NJ, Page R, Hansell DM, Field JK. UK Lung Screen (UKLS) nodulemanagement protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax 2011;66:308-13.
8. Van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, et al. Management of lung nodules detected by volum CT screening. N Engl J Med 2009;361:2221-9.
9. Cassidy A, Duffy SW, Myles JP, Liloglou T, Field JK. Lung cancer risk prediction: a tool for early detection. Int J Cancer 2007;120:1-6.
10. Duffy SW, Raji OY, Agbaje OF, Allgood PC, Cassidy A, Field JK. Use of lung cancer risk models in planning research and service programs in CT screening for lung cancer. Expert Rev Anticancer Ther 2009;9:1467-72.
11. Field JK, Raji OY. The potential for using risk models in future lung cancer screening trials. F1000 Med Rep 2010;2: pii:38.
12. Field JK, Chen Y, Marcus MW, Mcronald FE, Raji OY, Duffy SW. The contribution of risk prediction models to early detection of lung cancer. J Surg Oncol 2013;108:304-11.
13. Bach PB, Kattan MW, Thornquist MD, Kris MG, Tate RC, Barnett MJ, et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst 2003;95:470-8.
14. Spitz MR, Hong WK, Amos CI, Wu X, Schabath MB, Dong Q, et al. A risk model for prediction of lung cancer. J Natl Cancer Inst 2007;99:715-26.
15. Cassidy A, Myles JP, Van TM, Page RD, Liloglou T, Duffy SW, et al. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer 2008;98:270-6.
16. Tammemagi CM, Pinsky PF, Caporaso NE, Kvale PA, Hocking WG, Church TR, et al. Lung cancer risk prediction: prostate, lung, colorectal and ovarian cancer screening trial models and validation. J Natl Cancer Inst 2011;103:1058-68.
17. Tammemagi MC, Katki HA, Hocking WG, Church TR, Caporaso N, Kvale PA, et al. Selection criteria for lung-cancer screening. N Engl J Med 2013;368:728-36.
18. Raji OY, Duffy SW, Agbaje OF, Baker SG, Christiani DC, Cassidy A, et al. Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a casecontrol and cohort validation study. Ann Intern Med 2012;157:242-50.
19. Veronesi G, Maisonneuve P, Rampinelli C, Bertolotti R, Petrella F, Spaggiari L, et al. Computed tomography screening for lung cancer: results of ten years of annual screening and validation of cosmos prediction model. Lung Cancer 2013;82:426-30.
20. Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 2006;26:565-74.
21. Hoggart C, Brennan P, Tjonneland A, Vogel U, Overvad K, Ostergaard JN, et al. A riskmodel for lung cancer incidence. Cancer Prev Res 2012;5:834-46.
22. Riboli E, Kaaks R. The EPIC Project: rationale and study design. European prospective investigation into cancer and nutrition. Int J Epidemiol 1997;26:S6-14.
23. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113-24.
24. Boeing H, Wahrendorf J, Becker N. EPIC-Germany-A source for studies into diet and risk of chronic diseases. European investigation into cancer and nutrition. Ann Nutr Metab 1999;43:195-204.
25. Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 2004;23:2109-23.
26. Rousson V, Zumbrunn T. Decision curve analysis revisited: overall net benefit, relationships to ROC curve analysis, and application to casecontrol studies. BMC Med Inform Decis Mak 2011;11:45.
27. Available from: www.mskcc.org/research/epidemiology-biostatistics/health-outcomes/decision-curve-analysis-0. 2014.
28. Leffondre K, Abrahamowicz M, Siemiatycki J, Rachet B. Modeling smoking history: a comparison of different approaches. Am J Epidemiol 2002;156:813-23.
29. Lubin JH, Alavanja MC, Caporaso N, Brown LM, Brownson RC, Field RW, et al. Cigarette smoking and cancer risk: modeling total exposure and intensity. Am J Epidemiol 2007;166:479-89.
30. Vlaanderen J, Portengen L, Schuz J, Olsson A, Pesch B, Kendzia B, et al. Effect modification of the association of cumulative exposure and cancer risk by intensity of exposure and time since exposure cessation: a flexible method applied to cigarette smoking and lung cancer in the SYNERGY Study. Am J Epidemiol 2014;179:290-8.
31. Steyerberg EW, Vickers AJ. Decision curve analysis: a discussion. MedDecis Making 2008;28:146-9.
32. Van Calster B, Vickers AJ. Calibration of Risk Prediction Models: Impact on Decision-Analytic Performance. Med Decis Making 2015;35:162-9.
33. Patz EF Jr, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemagi MC, et al. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med 2014;174:269-74.
34. Chien CR, Chen TH. Mean sojourn time and effectiveness of mortality reduction for lung cancer screening with computed tomography. Int J Cancer 2008;122:2594-99.
35. Black WC, Gareen IF, Sneji SS, Sicks JD, Keeler EB, Aberle DR, et al. Costeffectiveness of CT screening in the National Lung Screening Trial. N Engl J Med 2014;371:1793-802.
36. Burns DM., Lee L, Shen LZ., Gilpin E, Tolly HD., Vaughn J, et al. Cigarette smoking behavior in the United States. In: Tobacco Control Monograph Series, No 8: Changes in Cigarette-Related Disease Risks and Their Implication for Prevention and Control. 2014. Available from: http://cancercontrol.cancer.gov/brp/tcrb/monographs/8/index.html.
37. Forey BA, Hamling J, Hamling J, Lee P. International smoking statistics (web edition): a collection of worldwide historical data, Australia. P N Lee Statistics and Computing Ltd. 2010. Available from: http://www.pnlee.co. uk/Downloads/ISS/ISS-Australia-061219.pdf
38. Wender R, Fontham ET, Barrera E Jr, Colditz GA, Church TR, Ettinger DS, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 2013;63:107-17.
39. Jacobson FL, Austin JH, Field JK, Jett JR, Keshavjee S, MacMahon H, et al. Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for lung cancer screening and surveillance. J Thorac Cardiovasc Surg 2012;144:25-32.
40. Wood DE, Eapen GA, Ettinger DS, Hou L, Jackman D, Kazerooni E, et al. Lung cancer screening. J Natl Compr Canc Netw 2012;10:240-65.
41. Moyer VA. U. S. Preventive Services Task Force. Screening for lung cancer: U. S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160:330-8.